"527604"^^ . . "J06Y7MXW4D"^^ . "CHEBI:4356"^^ . . "DEFEROXAMINEPTFDAJ06Y7MXW4D" . . "deferoxaminePTNCI-GLOSSCDR0000045388" . "Organic Chemical"^^ . "Deferoxamine"^^ . . . "DesferrioxamineSYNCI" . "An iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and siderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile. This agent does not readily bind iron from transferrin, hemoglobin, myoglobin or cytochrome. (NCI04)NCI" . "Pharmacologic Substance"^^ . . "Deferoxamine"^^ . "Deferoxamine"^^ . "DeferoxaminePTNCI" . "N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamideSNNCI" . "DesferrioxamineSYDTPNSC0527604" . "FDA"^^ . "N-[5-[3-[5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic AcidSNNCI" . "C416"^^ . "1-Amino-6,17-dihydroxy-7,10,18,21-tetraoxo-27-(n-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosaneSNNCI" . "C0011145"^^ . "An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death. It is used in conjunction with other anticancer agents in pediatric neuroblastoma therapy.NCI-GLOSS" . "70-51-9"^^ . . "N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamidePTDCP09403" . "C25H48N6O8"^^ .